We are live on ! Find out more
PR

Payden & Rygel Portfolio holdings

AUM $1.3B
1-Year Est. Return 28.32%
This Fund
S&P 500
This Quarter Est. Return
+9.64%
1 Year Est. Return
+28.32%
3 Year Est. Return
+89.13%
5 Year Est. Return
+123.15%
10 Year Est. Return
+353.66%
AUM
$1.21B
AUM Growth
-$1.88M
Cap. Flow
-$98.4M
Cap. Flow %
-8.16%
Top 10 Hldgs %
29.75%
Holding
126
New
13
Increased
20
Reduced
44
Closed
13

Top Buys

Rank Stock Value
1
CVS icon
CVS Health
CVS
+$17.9M
2
VLO icon
Valero Energy
VLO
+$16.7M
3
ADI icon
Analog Devices
ADI
+$16.4M
4
MRK icon
Merck
MRK
+$16M
5
CVX icon
Chevron
CVX
+$15.3M

Top Sells

Rank Stock Value
1
XOM icon
ExxonMobil
XOM
+$25.9M
2
AJG icon
Arthur J. Gallagher & Co
AJG
+$18.1M
3
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$15.9M
4
DHR icon
Danaher
DHR
+$15.6M
5
HCA icon
HCA Healthcare
HCA
+$15.5M

Sector Composition

Rank Sector Weight
1 Financials 19.47%
2 Technology 14.69%
3 Healthcare 11.02%
4 Industrials 9.65%
5 Communication Services 7.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GLW icon
26
Corning
GLW
$126B
$18.2M 1.51%
222,000
– –
DGX icon
27
Quest Diagnostics
DGX
$25.1B
$18M 1.49%
94,200
+600
+0.6% +$106K
META icon
28
Meta Platforms (Facebook)
META
$1.51T
$17.5M 1.45%
23,810
-4,700
-16% -$3.5M
MCK icon
29
McKesson
MCK
$98.5B
$17.2M 1.43%
22,300
-10,000
-31% -$7.04M
VOO icon
30
Vanguard S&P 500 ETF
VOO
$968B
$17M 1.41%
27,800
-2,659
-9% -$1.57M
ADI icon
31
Analog Devices
ADI
$181B
$16.8M 1.39%
+68,300
New +$16.4M
MRK icon
32
Merck
MRK
$324B
$16.6M 1.38%
197,910
+194,200
+5,235% +$16M
CVX icon
33
Chevron
CVX
$388B
$15.6M 1.29%
100,400
+98,900
+6,593% +$15.3M
ETN icon
34
Eaton
ETN
$157B
$15.4M 1.28%
41,200
-800
-2% -$291K
VZ icon
35
Verizon
VZ
$194B
$15.4M 1.28%
349,890
-52,000
-13% -$2.25M
PEP icon
36
PepsiCo
PEP
$186B
$15.3M 1.26%
108,600
+99,400
+1,080% +$14.2M
SPG icon
37
Simon Property Group
SPG
$74.5B
$15M 1.24%
79,850
+14,200
+22% +$2.45M
AVGO icon
38
Broadcom
AVGO
$1.82T
$14.9M 1.24%
45,300
-2,100
-4% -$644K
ITT icon
39
ITT
ITT
$17.5B
$14.9M 1.24%
83,500
-300
-0.4% -$50.3K
J icon
40
Jacobs Solutions
J
$15.9B
$13.9M 1.15%
92,700
+11,400
+14% +$1.64M
ABBV icon
41
AbbVie
ABBV
$458B
$13.3M 1.1%
57,410
+57,300
+52,091% +$11.7M
EPD icon
42
Enterprise Products Partners
EPD
$83.8B
$13M 1.08%
417,070
-203,800
-33% -$6.43M
ET icon
43
Energy Transfer Partners
ET
$70.1B
$12.9M 1.07%
750,690
-251,100
-25% -$4.4M
PLD icon
44
Prologis
PLD
$138B
$12.8M 1.06%
111,700
+26,200
+31% +$2.88M
RTX icon
45
RTX Corp
RTX
$287B
$12.8M 1.06%
76,400
– –
MCD icon
46
McDonald's
MCD
$188B
$12.6M 1.05%
41,600
+19,500
+88% +$5.93M
JNJ icon
47
Johnson & Johnson
JNJ
$635B
$12M 1%
64,900
– –
SYK icon
48
Stryker
SYK
$127B
$11.9M 0.99%
32,300
-21,200
-40% -$8.19M
CI icon
49
Cigna
CI
$76.6B
$11.2M 0.93%
38,800
+7,500
+24% +$2.22M
AXP icon
50
American Express
AXP
$223B
$10.9M 0.9%
32,700
-34,700
-51% -$11M
1
2
3 4 5

Similar funds

GPCM
Greenbrier Partners Capital Management Dallas, Texas $1.3B AUM 21.43% 1-Year Est. Return
PWP
Private Wealth Partners Mill Valley, California $1.3B AUM 26.2% 1-Year Est. Return
MCM
Mainstay Capital Management Grand Blanc, Michigan $1.3B AUM 37.8% 1-Year Est. Return
SPC
Silver Point Capital Greenwich, Connecticut $1.3B AUM 18.3% 1-Year Est. Return
HCS
Himension Capital (Singapore) Singapore $1.3B AUM 85.53% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
SP
Sherman Porfolios Coeur D'alene, Idaho $1.3B AUM 35.18% 1-Year Est. Return
CCFM
Clear Creek Financial Management Silverdale, Washington $1.3B AUM 20.31% 1-Year Est. Return

Payden & Rygel's Q3 2025 Portfolio in Review

As of Q3 2025, Payden & Rygel held 126 positions worth $1.21B, down 0.16% from $1.21B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Payden & Rygel withdrew a net $98.4M in Q3 2025, closing 13 positions and reducing 44 holdings. Its most notable exit was Berkshire Hathaway Class B, an estimated $15.9M position sold in full.

By sector, the portfolio is most concentrated in Financials at 19% of assets, down from 26% a quarter earlier, followed by Technology and Healthcare.

Against the trend, Payden & Rygel opened a new position in CVS Health worth $19.7M.

  • Payden & Rygel's largest Q3 2025 buy was CVS Health: 261,500 shares worth $19.7M.
  • Payden & Rygel added most to Merck in Q3 2025, an estimated $16M increase.
  • Payden & Rygel's biggest Q3 2025 reduction was ExxonMobil, cutting an estimated $25.9M.
  • Payden & Rygel fully exited Berkshire Hathaway Class B in Q3 2025, selling an estimated $15.9M.
  • Payden & Rygel's ten largest holdings make up 30% of its $1.21B portfolio in Q3 2025.
  • Payden & Rygel opened 13 new positions and closed 13 in Q3 2025.
  • Payden & Rygel's portfolio value fell 0.16% quarter-over-quarter to $1.21B.

Based on Payden & Rygel's 13F filing for Q3 2025, filed 10 Nov 2025.